We are attending AASLD The Liver Meeting® 2025 in Washington D.C.

Denifanstat improves multiple qFibrosis-based collagen features linked to major adverse liver outcomes in patients with metabolic dysfunction-associated steatohepatitis patients and high polygenic risk

-SAT_437_EASL2025